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Abstract
Background: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by the selective loss of
motor neurons (MN) in the brain stem and spinal cord. Intracellular disruptions of cytosolic and mitochondrial calcium have
been associated with selective MN degeneration, but the underlying mechanisms are not well understood. The present evidence
supports a hypothesis that mitochondria are a target of mutant SOD1-mediated toxicity in familial amyotrophic lateral sclerosis
(fALS) and intracellular alterations of cytosolic and mitochondrial calcium might aggravate the course of this neurodegenerative
disease. In this study, we used a fluorescence charged cool device (CCD) imaging system to separate and simultaneously monitor
cytosolic and mitochondrial calcium concentrations in individual cells in an established cellular model of ALS.
Results: To gain insights into the molecular mechanisms of SOD1G93A associated motor neuron disease, we simultaneously
monitored cytosolic and mitochondrial calcium concentrations in individual cells. Voltage – dependent cytosolic Ca2+ elevations
and mitochondria – controlled calcium release mechanisms were monitored after loading cells with fluorescent dyes fura-2 and
rhod-2. Interestingly, comparable voltage-dependent cytosolic Ca2+ elevations in WT (SH-SY5YWT) and G93A (SH-SY5YG93A)
expressing cells were observed. In contrast, mitochondrial intracellular Ca2+ release responses evoked by bath application of
the mitochondrial toxin FCCP were significantly smaller in G93A expressing cells, suggesting impaired calcium stores.
Pharmacological experiments further supported the concept that the presence of G93A severely disrupts mitochondrial Ca2+
regulation.
Conclusion: In this study, by fluorescence measurement of cytosolic calcium and using simultaneous [Ca2+]i and [Ca2+]mito
measurements, we are able to separate and simultaneously monitor cytosolic and mitochondrial calcium concentrations in
individual cells an established cellular model of ALS. The primary goals of this paper are (1) method development, and (2)
screening for deficits in mutant cells on the single cell level. On the technological level, our method promises to serve as a
valuable tool to identify mitochondrial and Ca2+-related defects during G93A-mediated MN degeneration. In addition, our
experiments support a model where a specialized interplay between cytosolic calcium profiles and mitochondrial mechanisms
contribute to the selective degeneration of neurons in ALS.
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Background
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegen-
erative disorder characterized by a selective loss of motor
neurons (MNs) in the brain stem, the spinal cord and the
motor cortex, leading to progressive weakness, muscle
atrophy with eventual paralysis, and death. Approxi-
mately 5–10% of ALS cases are familial [1,2]. A decade
ago, researchers discovered missense mutations in the
gene encoding the Cu/Zn superoxide dismutase 1 (SOD1)
in subsets of familial cases; approximately 20% of familial
ALS (fALS) is caused by mutations in SOD1 with high
inter-subject variation of progression, including the point
mutation G93A [3-7]
Multiple cascades have been implicated in the motor neu-
ron death pathway, including mitochondrial dysfunction
and deformities [8-15]; complex I, III, and IV abnormali-
ties [16-19]; mitochondrial alteration, increase in Ca2+
uptake and increase of cytosolic Ca2+  concentration
[6,20], oxidative stress [21]; and glutamate excitotoxicity
[22-29]. Alteration and disruption of calcium homeosta-
sis and metabolism [30-40] has also been reported.
The present evidence supports a hypothesis that mito-
chondrial dysfunction acts with oxidative stress to cause
abnormal neurodegeneration via calcium-mediated MN
injury. Oxidative stress may lead to increased intracellular
calcium, which leads to increased nitric oxide and perox-
ynitrite formation [21]. Glutamate excitotoxicity may dis-
rupt intracellular calcium homeostasis and reactive
oxygen species (ROS) production [27], which may be pro-
moted by oxidative stress as glutamate transporters are
particularly susceptible to disruption by oxidants, and
oxidative modifications to the transporter have been
reported in ALS and the mtSOD1G93A  mouse model
[24,21]. The etiology is likely to be multifactorial because
ALS involves the interplay of several mechanisms to initi-
ate disease and propagate the spread of motor neuron cell
death [36,38,39].
Mitochondrial Ca2+  uptake responds dynamically and
sensitively to changes in cytosolic Ca2+ levels and plays a
crucial role in sequestering the large Ca2+ loads induced by
FCCP-evoked Ca2+ influx [41]. The excessive influx of Ca2+
into mitochondria may result in mitochondrial dysfunc-
tion. Prominent and sustained mitochondrial depolariza-
tion follows intense ion channel receptor stimulation and
closely parallels the incidence of neuronal death [42].
Substantial Ca2+ can be accumulated in mitochondria as a
result of overloading the matrix with Ca2+; this disrupts
the structural and functional integrity of the organelle.
Hence, mitochondria may be a critical intracellular target
of injury after intense Ca2+ channel stimulation and, in
this way, may act as a link between massive Ca2+ influx
and mitochondria-mediated neurotoxicity by
mtSOD1G93A. However, the precise relationship between
Ca2+ influx, cytosolic Ca2+ increase, and mitochondrial
Ca2+ uptake remains obscure.
Culture systems, such as slice culture or primary cultures
of MN, have proven to be valuable tools in the physiolog-
ical and biochemical characterization of ALS-related
pathology [43-45]. Still unknown is whether the presence
of mtSOD1G93A  causes morphological mitochondrial
abnormalities when expressed at physiological levels,
whether the source specificity of mitochondrial Ca2+
sequestration and spatiotemporal properties of cytosolic
Ca2+ ([Ca2+]i) signaling in cells transfected with wild-type
and G93A-mutant SOD1 varies at physiological levels,
and if there are functional consequences of changes in
mitochondrial function on Ca2+ homeostasis in the pres-
ence of mtSOD1G93A. To elucidate the underlying molec-
ular events and cellular alterations involved in oxidative
stress induced by the aberrant Cu-Zn chemistry and the
roles of impaired Ca2+  handling and oxidative stress
induced by ROS in fALS, we used SH-SY5Y neuroblastoma
cells transfected with the G93A mutant form of SOD1 typ-
ical for fALS (SH-SY5YG93A or G93A) and SH-SY5Y cells
transfected with wild-type (WT) human SOD1  (SH-
SY5YWT or WT) and mimic the situation present in heter-
ozygous patients, previously established as an in-vitro cell
culture model of ALS, resembling the situation of hetero-
zygous patients [6,46]. This particular mutation was cho-
sen because it does not affect the activity of SOD1;
previously it was shown that SH-SY5Y cells expressing
G93A exhibit increased intracellular ROS [47]. The effect
of the continuous expression of WT or G93A on mito-
chondrial morphology and Ca2+  signaling were com-
pared. In addition, the consequences and impact of
protonophore FCCP and other organelle-specific drugs on
mitochondrial vulnerability and Ca2+ homeostasis were
studied.
Methods
SH-SY5YWT and SH-SY5YG93A transfected neuroblastoma 
cell cultures
An in-vitro model to study the cellular alterations associ-
ated with mutations of SOD1 was constructed by transfec-
tion of the human neuroblastoma cell line SH-SY5Y with
G93A-SOD1 [6]. The cell types that we have used in our
study are well characterized and have been used as cellular
model system for motoneuron disease by several groups
[6,48-50]. The transfected cell lines have relatively low
levels of mtSOD/wtSOD and are therefore an attractive
model system for the human disease [50]. Upon expres-
sion of fALS – SOD1, these cells show several features typ-
ical of neurons of both ALS patients and transgenic mice,
such as mitochondrial alteration, increased ROS levels
and increased cytosolic calcium concentration [see refer-
ences in [49]].BMC Neuroscience 2009, 10:64 http://www.biomedcentral.com/1471-2202/10/64
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Transfected human neuroblastoma cell lines constitu-
tively expressing either WT human SOD1 or the G93A
mutant form of this enzyme associated with fALS were
routinely maintained in Dulbecco's Modified Eagle
Medium (DMEM)-F12 (Gibco, Invitrogen, Karlsruhe,
Germany) containing 15% fetal calf serum (FCS; Bio-
chrom, Berlin, Germany), 100 U/ml penicillin (Bio-
chrom, Berlin, Germany), and 100 μg/ml streptomycin
(Gibco, Invitrogen, Karlsruhe, Germany) at 37°C in a
humidified atmosphere with 5% CO2 [6]. The cell lines
were under consistent selection by addition of 200 μg/ml
geneticin (G418 sulfate, Gibco, Invitrogen, Karlsruhe,
Germany), which was removed two days before perform-
ing the experiments.
Intracellular fluorometric Ca2+ measurements
The calcium-sensitive fluorescent dye, Fura-2, was intro-
duced into cells by loading the membrane-permeable AM-
ester forms (5 μM, 30 min, 37°C, 5% CO2 and 95% O2),
which is termed bolus loading. Fura-2 AM was purchased
from Invitrogen (Carlsbad, CA, USA) and freshly dis-
solved in dimethyl sulfoxide (DMSO) containing 10%
pluronic acid before the experiment. Changes in [Ca2+]i
were measured in non-transfected SH-SY5Y cells (Parental
cell line) and SH-SY5Y cells expressing WT or G93A
attached to glass cover slips after 2–5 days in culture. Cell
layers were incubated with RPMI-1640 (Biochrom, Berlin,
Germany) containing 10% FCS (Gibco, Invitrogen, Karl-
sruhe, Germany) and 0.846 mM Ca2+ (supplier's data).
Cells were rinsed with RPMI -1640 and incubated for 20
min at 37°C to allow for complete de-esterification.
Changes in [Ca2+]i were monitored by the excitation of
Fura-2 AM at 360 nm and 390 nm; emitted light was
directed to a dichroic mirror by a beam splitter at 425 nm.
In the case of non-transfected SH-SY5Y cells, the excita-
tion of Fura-2 AM was performed at 356 nm and 385 nm
and the emitted light was directed to a dichroic mirror
with mid-reflection at 425 nm. In some experiments, the
light was filtered by a band pass filter of 505–530 nm [See
Additional file 1]. Since the background fluorescence is
not clearly determinable in AM loaded cells, we regarded
the calculated Ca2+ concentrations as an approximation of
the real concentration [19]. Therefore, for ester-loaded
cells, changes in [Ca2+]i are given as changes in the Fura-2
ratio (360/390 nm).
Fura-2 (Kd ~ 0.2 μM) was monitored by a computer-con-
trolled monochromator (Polychrome II, TILL Photonics,
Germany), which was connected to an Axioscope micro-
scope (Zeiss, Goettingen, Germany) via quartz fiber optics
and a minimum number of optical components for max-
imum fluorescence excitation (objective Achroplan W
63x, 0.9W). The apparatus was equipped with a CCD cam-
era system [51,52], which displayed 12-bit dynamics
(PCO, Germany), and an A/D converter with a 12.5 MHz
sampling rate; the binning was set to 4 × 4 and the expo-
sure time was 30–80 ms. Calcium changes in defined
regions of interest (ROIs) were monitored online using
TILL Vision Software V3.3 (TILL Photonics, Martinsried,
Germany). The measured fluorescence ratio at the selected
wavelengths was used to calculate the [Ca2+]i and was rep-
resented as F/F0. Further analysis was performed off-line
with the IGOR software (Wavemetrics, Lake Oswego, OR,
USA) and Origin software, version 7.5.
Simultaneous recording of changes in [Ca2+]i and 
[Ca2+]mito
Simultaneous fluorometric measurements of [Ca2+]i and
mitochondrial calcium ([Ca2+]mito) were performed uti-
lizing calcium-sensitive fluorescent dyes (Fura-2 AM for
cytosolic calcium and Rhod-2 AM for mitochondrial cal-
cium). SH-SY5Y cells expressing either WT or G93A were
attached to glass cover slips and loaded initially with 5 μM
Fura-2 AM at 37°C for 30 min as described above. Subse-
quently, cells were washed with RPMI-1640 for 20 min
and further incubated with 10 μM Rhod-2 AM for 20 min
at 37°C (5% CO2 and 95% O2). The coverslips were
rinsed with RPMI-1640 and further incubated for 20 min
at 37°C to allow for complete de-esterification.
To clearly separate and simultaneously monitor the
dynamic [Ca2+]i and [Ca2+]mito profiles with a temporal
resolution in the millisecond time domain, we utilized a
computer-controlled monochromator that rapidly
switched between excitation wavelengths of 390 nm
(Fura-2) and 550 nm (Rhod-2) and collected wavelengths
above 565 nm for both excitation conditions. Schematic
representation of the CCD-imaging setup used for con-
ventional calcium imaging and simultaneous imaging of
[Ca2+]i and [Ca2+]mito signals in the cell line preparation
are illustrated in Additional file 1 [See Additional file 1].
For kinetic data analysis, only Fura-2 and Rhod-2 signals
from pre-defined regions of cells were used.
The accumulations of mitochondrial and other cell
organelles calcium were inhibited by cell organelles spe-
cific drug modulators. First, drugs were used, including
KCl (K+), depolarisation stimulus; FCCP, a protonophore;
and oligomycin (oligo), a F1, F0-ATPase blocker prevent-
ing maintenance of the proton gradient, which disrupt the
mitochondrial membrane potential (ΔΨm) [53-56]. Sec-
ondly, by thapsigargin (thapsi) an extremely tight binding
inhibitor of intracellular Ca2+  pumps, which raises
cytosolic calcium concentration by blocking the ability of
the cell to pump calcium into the sarcoplasmic and endo-
plasmic reticulum which causes these stores to become
depleted [57]. Store-depletion can secondarily activate
plasma membrane calcium channels, allowing an influx
of calcium into the cytosol. Thirdly, by caffeine, a specificBMC Neuroscience 2009, 10:64 http://www.biomedcentral.com/1471-2202/10/64
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activator of Ca2+ influx from ryanodine receptor (RyR)-
dependent Ca2+ stores [58].
Statistical analysis
Each cover slip was used for a single experiment and
included more than 4 cells for each imaging experiment.
Unless otherwise indicated, values in the text are given as
mean ± standard deviation (SD) and the error bars indi-
cate SD too. All values represent at least three separate
experiments. Significance was calculated using the two
tailed unpaired Student t-test. A p-value < 0.05 was con-
sider statistically significant. Five point smoothing was
performed in the case of simultaneous [Ca2+]i and
[Ca2+]mito signals to remove the noise.
Chemical induction of calcium release
Carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone
(FCCP), thapsigargin, and oligomycin were purchased
from Sigma-Aldrich Chemie (Deisenhoff, Germany).
FCCP was bath applied at a dose of 2 μM. A comparative
analysis of the Ca2+ influx in WT and G93A transfected
cells was done in the presence of FCCP. For these experi-
ments the SH-SY5Y cells were loaded with 5 μM Fura-2
AM through the incubation method and [Ca2+]i transients
were triggered once Fura-2 AM concentration was equili-
brated after washing. Ca2+ release from intracellular stores
by inhibition of the sarcoplasmic/endoplasmic reticulm
Ca2+-dependent ATPase pump and inhibition of F1, F0-
ATP Synthase was done by intervention of thapsi, and
oligo, respectively.
For the investigation of endoplasmic reticulum (ER)-
dependent Ca2+ release, caffeine has been established as a
specific activator of Ca2+ influx from the RyR-dependent
Ca2+ stores [58]. To investigate the relative impact of the
ER and mitochondria in [Ca2+]i regulation together with
the association on MN degeneration in G93A transfected
SH-SY5Y cells, we used pharmacological agents as a spe-
cific activator of the ER-dependent Ca2+ release response
[59], which not only selectively blocks Ca2+ uptake into
ER/mitochondrial compartments but also triggers Ca2+
release from intracellular storage sites. Caffeine was pur-
chased from Sigma-Aldrich chemie (Deisenhofen, Ger-
many) and dissolved in water (25 mM). It was then
diluted to the final concentration immediately before the
experiment. We utilized KCl (K+) concentrations of 30
mM for depolarisation induced Ca2+ transients.
Results
Impaired mitochondrial responses of cytosolic calcium in 
G93A transfected cells
Representative non-transfected SH-SY5Y neuroblastoma
cells (parental cell line) stained with Fura-2 AM are shown
in Additional file 2 [See Additional file 2]. Mitochondrial
Ca2+ release responses were measured to verify the impact
of mitochondrial uncoupler FCCP in normal SH-SY5Y
cells. The application of FCCP for 2 min fairly inhibited
mitochondrial Ca2+ and most of the cells had a proper dis-
tinguishable and characteristic fluorescence response (See
Additional file 2]. In the cells matching set criteria, includ-
ing a normal morphological appearance of a large soma
and intense proper staining, we performed Ca2+ imaging
2–5 days after culture from WT-SOD1 and G93A trans-
fected SH-SY5Y cells.
The transfected cells were treated with FCCP (3 min) and
the [Ca2+]i measured for both WT and G93A-transfected
SH-SY5Y cells (Fig. 1). A CCD imaging photomicrograph
series of [Ca2+]i in 7–8 cells before drug application
(0.0s), after peak FCCP challenge (3 min), and after FCCP
wash in WT-SOD1 (a-c) and G93A (d-f) transfected cells
are shown in Fig. 1A. Figs. 1B and 1C show [Ca2+]i as cyto-
plasmic calcium versus time curves in 6 representative
cells during FCCP challenge. The mitochondrial uncou-
pler induces a fast transient elevation in [Ca2+]i and a fast
recovery to baseline in WT transfected cells (Fig. 1B, F/F0
= 0.1766 ± 0.0362; N = 3, n = 17). The G93A transfected
cells had a comparatively lower fluorescence intensity for
transient elevation in [Ca2+]i followed by a delayed recov-
ery to baseline (Fig. 1C, F/F0 = 0.0948 ± 0.0223; N = 5, n
= 23). The FCCP-induced calcium influx peak fluores-
cence intensity in G93A transfected cells was diminished
by approximately 48% compared to the calcium influx
peak fluorescence intensity of WT transfected cells (Fig.
1D; p < 0.001).
Calcium uptake by the mitochondria is accomplished by
the mitochondrial calcium uniporter (MCU) located in
the inner mitochondrial membrane [60]. The accumula-
tion of mitochondrial Ca2+ may have a perceptible influ-
ence on the existence of a [Ca2+]i transient. This effect was
studied by following the Ca2+ signal under healthy and
deleterious mitochondrial conditions in the presence of
FCPP. We found that, in G93A transfected SH-SY5Y cells,
the Ca2+ influx (peak fluorescence) was diminished com-
pared to WT transfected SH-SY5Y cells, which, peaked
within 2–3 min and was followed by a baseline recovery
in approximately 2 min. The G93A transfected cells took
almost 5–6 min to achieve a baseline recovery. However,
the cells transfected with G93A suffered from reduced
[Ca2+]mito after depletion of mitochondrial Ca2+ stores by
FCCP (Fig. 1).
Effect of high K+-evoked Ca2+ transient and its impact on 
FCCP-induced Ca2+ influx
To analyze the comparative efficiency of mitochondria as
a Ca2+ sequestering organelle, FCCP was applied to evacu-
ate mitochondrial Ca2+after the WT and G93A transfected
cells had been exposed to an evoked Ca2+ load through a
depolarizing stimulus of K+. First, the SH-SY5Y cells trans-
fected with WT or G93A were stained with Fura-2 AM and
exposed to 30 mM K+ for 30 sec, which was followed by aBMC Neuroscience 2009, 10:64 http://www.biomedcentral.com/1471-2202/10/64
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3 min challenge with FCCP (Fig. 2). As shown in Figs. 2A
and 2B, the peak amplitude of FCCP-evoked Ca2+ influx
after depolarization was 0.2440 ± 0.0696 (N = 3, n = 20)
and 0.1497 ± 0.0362 (N = 5, n = 20) for the WT and G93A
transfected cells, respectively. Fig. 2C shows the compara-
tive analysis of average calcium release.
Interaction between ER/mitochondria in differential Ca2+ 
store regulation by inhibition of the sarcoplasmic/
endoplasmic reticulm Ca2+-dependent ATPase pump after 
pharamacological intervention
The relationships between mitochondrial calcium pools
and those discharged by the Ca2+-ATPase inhibitor thapsi,
an extremely tight-binding inhibitor of intracellular Ca2+
pumps which induces rapid Ca2+ release from intracellular
stores by inhibition of the sarcoplasmic/endoplasmic
reticulm Ca2+-dependent ATPase pump without inositol
phosphate formation [57,61] were studied in WT and
G93A transfected SH-SY5Y cells to estimate reciprocal
functional interplay between the ER and mitochondria. It
was previously shown in SOD1G93A mice that release of ER
based Ca2+ stores play minimal role and not an essential
factors in the death mechanism of ALS vulnerbale MNs
[62]. However, contrary to this study it was also shown
that Ca2+ release from the ER contributes to neuronal cell
death because the Ca2+release blocker, dantrolene, can
FCCP induced mitochondrial depolarization in SH-SY5Y neuroblastoma cells transfected with G93A exhibits reduced peak flu- orescence amplitude Figure 1
FCCP induced mitochondrial depolarization in SH-SY5Y neuroblastoma cells transfected with G93A exhibits 
reduced peak fluorescence amplitude. A) A CCD imaging photomicrograph series showing [Ca2+]i in 7–8 cells before 
drug application (0.0s), after peak 2 μM FCCP challenge for 3 min, and after FCCP wash in WT (a-c) and G93A (d-f) trans-
fected SH-SY5Y neuroblastoma cells. B) A representative figure of [Ca2+]i fluorescence intensity in 6 SH-SY5Y neuroblastoma 
cells transfected with WT after FCCP application. FCCP (2 μM) induced a fast, transient elevation in [Ca2+]i and a fast recovery 
to baseline. C) In G93A transfected SH-SY5Y neuroblastoma cells, FCCP induced a transient elevation in [Ca2+]i fluorescence 
intensity that was lower in magnitude, followed by a plateau for 1 min, and a delayed recovery to baseline. D) A bar diagram to 
illustrate the reduction of the sustained Ca2+ response in G93A transfected SH-SY5Y neuroblastoma cells (F/F0 = 0.0948 ± 
0.0223; N = 5, n = 23) compared to WT transfected SH-SY5Y cells (F/F0 = 0.1766 ± 0.0362; N = 3, n = 17). Values represent 
means ± SD, **p < 0.001, scale bar = 10 μm. N = Number of experiments; n = Number of cells.BMC Neuroscience 2009, 10:64 http://www.biomedcentral.com/1471-2202/10/64
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protect neurons against bioenergetic failure and cellular
damage [63]. While little is known about the exact ER/
mitochondrial Ca2+ regulation mechanism in WT and
G93A transfected cells, the restoration of ER function or
attenuation of the secondary dysfunction induced by ER
could present a new, highly promising mechansim for
pharmacological intervention which could bring new
ways to treat or minimize neuronal cell injury in the path-
ological states of ALS.
Analysis of the Ca2+ storing ability of ER and mitochon-
dria in WT and G93A transfected cells was done using
thapsi and FCCP. We show here that in fura-2-loaded
cells, thapsi stimulated a slow plateau phase increase in
cytoplasmic Ca2+ concentration in WT and G93A trans-
fected cells. There was a significant quantitative difference
between the ER and mitochondrial Ca2+ load in WT and
G93A transfected cells; the Ca2+release response was high
in the mitochondria of WT transfected cells. As shown in
Fig. 3, the peak amplitude of mitochondrial Ca2+ release
after application of FCCP plus thapsi was 0.2712 ± 0.0971
and 0.1276 ± 0.0287 where as peak amplitude of ER Ca2+
release after application of thapsi was 0.0412 ± 0.0152
and 0.02589 ± 0.0137 in WT and G93A transfected cells,
respectively (Figs. 3A–C). The impact of thapsi on the
peak amplitude of Ca2+ release was nominal compared
with FCCP, indicating a lesser role for ER compared with
mitochondria in Ca2+ regulation. Comparative details of
the normalized fura-2 ratio in both WT and G93A trans-
fected cells are summarized in Fig. 3C (N = 3, n = 15).
Interaction of ER/Mitochondria calcium stores regulation 
by activation of Ca2+ influx from the RyR-dependent Ca2+ 
stores
As shown in Fig. 4, caffeine led to a relatively slow and
weak increase in the [Ca2+]i fluorescence signals, which
was very similar for both WT and G93A transfected cells
(N = 3, n = 14). We found that WT transfected cells (Figs.
4A and 4C) were affected by 5 mM caffeine with a small
and slow increase in [Ca2+]i (F/F0 = 0.0471 ± 0.0190) and
exhibited slightly higher kinetics than the G93A trans-
fected cells ([Ca2+]i: F/F0 = 0.0353 ± 0.0120; Figs. 4B and
4C). This suggests that the caffeine-evoked ER-dependent
Ca2+ release either makes only a minor contribution to
mitochondrial mediated toxicity in G93A transfected
cells, as reported in other cell types and animal models, or
occurs upstream of the mitochondria.
The cells were treated with FCCP in the presence of caf-
feine, which resulted in the depolarization of the mito-
chondria (Fig. 4). We observed a rapid and high
amplitude increase of [Ca2+]i, which exhibited a very dis-
tinct and differential response for WT and G93A trans-
fected cells (N = 3, N = 14). WT transfected cells revealed
that caffeine and FCCP together evoked a massive and
comparatively fast increase in the Fura-2 fluorescence sig-
The effect of high K+ (30 mM) – evoked Ca2+ transient and its impact on the FCCP-induced Ca2+ influx in WT and G93A trans- fected SH-SY5Y neuroblastoma cells Figure 2
The effect of high K+ (30 mM) – evoked Ca2+ transient and its impact on the FCCP-induced Ca2+ influx in WT 
and G93A transfected SH-SY5Y neuroblastoma cells. A) A representative figure showing effect of perturbing the mito-
chondrial Ca2+ uptake on the calcium transient evoked by 30 mM K+ depolarizing stimulus for 30s (red horizontal bar) and by 2 
μM FCCP-evoked Ca2+ efflux (black horizontal bar). FCCP (2 μM) induced a fast, transient elevation in [Ca2+]i and a fast recov-
ery to baseline after depolarization-induced stimulus in 7 SH-SY5Y cells transfected with WT. B) In G93A transfected SH-SY5Y 
cells, the FCCP-induced [Ca2+]i transient elevation after depolarization-induced stimulus was delayed 5–10s and there was a 
reduction in the magnitude of fluorescence intensity followed by complete recovery to baseline. C) A bar diagram to illustrate 
the reduction of the sustained Ca2+ response in G93A transfected SH-SY5Y neuroblastoma cells (F/F0 = 0.1497 ± 0.0362; N = 
5, n = 20) compared to WT transfected SH-SY5Y cells (F/F0 = 0.2440 ± 0.0696; N = 3, n = 20). Values represent means ± SD, 
**p < 0.001, scale bar = 20 μm. N = Number of experiments; n = Number of cells.BMC Neuroscience 2009, 10:64 http://www.biomedcentral.com/1471-2202/10/64
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nals for WT (F/F0 = 0.1883 ± 0.0584, Figs. 4A and 4C) and
G93A transfected cells (F/F0 = 0.1154 ± 0.0246, Figs. 4B
and 4C).
Manipulation of mitochondria in WT and G93A 
transfected SH-SY5Y cells by pharmacological Inhibition of 
F1, F0-ATP Synthase
As an uncoupler of mitochondria, FCCP collapses the
mitochondrial membrane potential. In turn, this results
in a rapid release of calcium from this store and a slower
drop in ATP levels [64]. Impairment of the mitochondria
with FCCP may block oxidative phosphorylation and has
the potential to compromise oxidative phosphorylation;
in this state, glycolysis provides the prime means of ATP
synthesis. Previously, evidence had suggested that ATP
depletion by FCCP in MNs leads to minimal effect on
reverse cycle of uncoupling of oxidative phosphorylation
([62], S. Balakrishnan and B.U. Keller, unpublish data).
We assume that the sole effect of FCCP on cells is the
uncoupling of mitochondria and that this results might
lead to a reduction of the proton gradient across the inter-
nal mitochondrial membrane. Oligo, an ATP synthase
inhibitor, also depletes ATP but does not alter mitochon-
drial membrane potential and thus does not change cal-
cium transport across the mitochondrial membrane.
Oligo was added with FCCP to prevent any accelerated
consumption of cellular ATP by the reverse mode of ATP
synthase operation [65,66].
To clarify this issue, we measure the impact of oligo (5 μg/
ml) on FCCP-induced Ca2+ release in WT and G93A trans-
fected SH-SY5Y cells loaded with fura-2. Very weak effects
to those previously observed with the electron transport
inhibitors (CN-) and azide were seen with oligomycin
[19,62]. As shown in Figs. 5A–C, impact of oligo's on the
normalized peak fluorescence of fura-2 was 0.0454 ±
0.0175 and 0.0229 ± 0.0161 for WT and G93A transfected
SH-SY5Y cells, respectively (Fig. 5C). The impact of oligo-
mycin on the peak amplitude of fura-2 fluorescence was
nominal and there was slight difference between WT and
G93A transfected SH-SY5Y cells. However, the response to
FCCP plus oligomycin in WT transfected cells (Fig. 5C)
was almost 2.71-fold higher (F/F0 = 0.2245 ± 0.0727)
compared with G93A transfected SH-SY5Y cells (F/F0 =
0.0827 ± 0.0304; Figs. 5A–C).
Simultaneous measurement of [Ca2+]i and [Ca2+]mito
Using FCCP to prevent a [Ca2+]mito increase while meas-
uring an increase in [Ca2+]i, we were able to efficiently
separate cytosolic and mitochondrial Ca2+ at a temporal
Analysis of the differential Ca2+ storage and regulation of the ER and mitochondria by pharmacological intervention in WT and  G93A transfected SH-SY5Y cells Figure 3
Analysis of the differential Ca2+ storage and regulation of the ER and mitochondria by pharmacological inter-
vention in WT and G93A transfected SH-SY5Y cells. Cells were stimulated using thapsi and FCCP, which interfere with 
the integrity of the ER and mitochondria, respectively, and were used to release Ca2+ from intracellular stores by inhibition of 
the sarcoplasmic/endoplasmic reticulm Ca2+-dependent ATPase pump and mitochondrial stores by protonophore action. A) 
The quantitative kinetic profile of the thapsi and FCCP-evoked [Ca2+]i release in WT transfected SH-SY5Y cells. B) The corre-
sponding quantitative kinetic profile of the thapsi and FCCP-evoked [Ca2+]i release in the G93A transfected SH-SY5Y cells. The 
trace is representative of mean of 4–6 cells in focus stimulated with thapsi (5 μg/ml; 6 min) and 2 μM FCCP (3 min, normalized 
data). The horizontal black bars indicate the duration of stimulation by thapsi and with FCCP plus thapsi. Fura-2 AM signals are 
represented as F/F0. C) A bar diagram of thapsi and FCCP plus thapsi-induced Ca2+ release in the WT and G93A transfected 
SH-SY5Y neuroblastoma cells (N = 3, n = 15). Gray bars represent thapsi plus FCCP-induced Ca2+ release in WT (F/F0 = 
0.2712 ± 0.0971) and G93A (F/F0 = 0.1276 ± 0.0287) transfected SH-SY5Y cells. Striped bars represent thapsi-induced Ca2+ 
release in WT (F/F0 = 0.0412 ± 0.0152) and G93A (F/F0 = 0.0258 ± 0.0137) transfected cells. Values represent means ± SD, *p 
< 0.01, **p < 0.001. N = Number of experiments; n = Number of cells.BMC Neuroscience 2009, 10:64 http://www.biomedcentral.com/1471-2202/10/64
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resolution in the millisecond time domain. As shown in
Fig. 1, the Ca2+ release in G93A transfected cells is smaller
in amplitude and exhibits slower kinetics compared to WT
transfected cells. To confirm that there are separate Ca2+
uptake and release events from the cytosol and mitochon-
dria, the transfected cells were treated with FCCP and the
separate Ca2+ levels measured simultaneously (Fig. 6). WT
transfected cells exhibited a substantial increase in [Ca2+]i
(F/F0 = 0.1569 ± 0.0235; Fig. 6A, N = 5; n = 17) while
[Ca2+]mito decreased (F/F0 = -0.1069 ± 0.0181, Fig. 6A, N
= 5; n = 17). This suggests that the FCCP-evoked increase
in [Ca2+]i in Fig. 1 was mainly due to [Ca2+]i and that
there was very little impact from [Ca2+]mito. In G93A
transfected cells, FCCP-evoked [Ca2+]i was less and exhib-
ited slower kinetics (F/F0 = 0.1008 ± 0.0248; Figs. 6B and
6C, N = 4; n = 17) compared to WT transfected cells,
which exhibited a reduction of the [Ca2+]mito (F/F0 = -
0.0486 ± 0.0043, Figs. 6B and 6C, N = 4; n = 17).
Discussion
Recent evidence suggests that abnormalities in cellular
Ca2+ signaling are common features in the pathogenesis of
a range of neurodegenerative disorders, including ALS
[33]. It is well known that Ca2+ is one of the most relevant
intracellular messengers essential in neuronal develop-
ment, synaptic transmission and plasticity, and the regu-
lation of various metabolic pathways in the brain. Further
evidence for the involvement of a disruption in intracellu-
lar Ca2+ homeostasis was reported in cellular and experi-
mental animal models; there was an absence of Ca2+
binding proteins, such as Calbindin-D28K and parvalbu-
min, in MN populations lost early in ALS [67]. Addition-
ally, accumulation of Ca2+ into vacuoles in the mtSOD1
mice and low Ca2+ buffering in SMNs were also shown
[68]. These findings agree with a quantitative comparison
of Ca2+homeostasis where a low cytosolic Ca2+ buffering
capacity acts as an important risk factor for degeneration.
In contrast, an increase in the cytosolic Ca2+ buffering
capacity could protect vulnerable MNs from degeneration
[69,35]. MNs store a larger amount of calcium in the
mitochondria and disruption of mitochondrial Ca2+
uptake has a marked influence on both the peak ampli-
tude of Ca2+ response as well as the clearance of [Ca2+]i.
Our interest in studying the role of Ca2+ regulation and the
impact of mitochondrial inhibition in a cellular model of
ALS is based on observations that mitochondria act as
local calcium buffers, thus shaping the spatiotemporal
aspects of [Ca2+]i. MN mitochondria have been shown to
have a major percentage of Ca2+ sequestered intracellu-
larly after influx through the plasma membrane [70,71].
Our main objective was to characterize the contribution
Impact of inhibition of F1, F0-ATP synthase on FCCP-evoked responses of [Ca2+]i in  WT and G93A transfected SH-SY5Y cells Figure 4
Impact of inhibition of F1, F0-ATP synthase on FCCP-evoked responses of [Ca2+]i in  WT and G93A trans-
fected SH-SY5Y cells. A) The quantitative kinetic profile of the oligo and FCCP-evoked [Ca2+]i release in WT transfected 
SH-SY5Y cells. B) The corresponding quantitative kinetic profile of the oligo and FCCP-evoked [Ca2+]i release in the G93A 
transfected SH-SY5Y cells. The trace is representative of mean of 4-6 cells in focus stimulated with oligo (5 μg/ml; 6 min) and 
2µM FCCP (3 min, normalized data). The horizontal black bars indicate the duration of stimulation by oligo and with FCCP plus 
oligo. Fura-2 AM signals are represented as F/F0. C) A bar diagram of oligo and FCCP plus oligo-induced Ca2+ release in the 
WT (N=3, n=20) and G93A (N=3, n=19) transfected SH-SY5Y neuroblastoma cells. Gray bars represent oligo plus FCCP-
induced Ca2+ release in WT (F/F0 = 0.2245 ± 0.0727) and G93A (F/F0 = 0.0827 ± 0.0304) transfected SH-SY5Y cells. Striped 
bars represent oligo-induced Ca2+ release in WT (F/F0 = 0.0454 ± 0.0175) and G93A (F/F0 = 0.0229 ± 0.0161) transfected 
cells. Values represent means ± SD, *p<0.01, **p<0.001. N= Number of experiments; n= Number of cells. BMC Neuroscience 2009, 10:64 http://www.biomedcentral.com/1471-2202/10/64
Page 9 of 16
(page number not for citation purposes)
of the mitochondrial buffering of voltage-activated Ca2+
loads and how this Ca2+ regulatory mechanism is control-
led. We observed that Ca2+ influx was diminished by
approximately 1.86 fold in the presence of G93A com-
pared to WT (Fig. 1). After exposure to FCCP, the capacity
of G93A transfected cells to transport [Ca2+]i to the extra-
cellular space or to intracellular storage sites was much
lower than WT transfected cells and accounted for the
increased vulnerability of cells possessing mutant G93A
gene.
Interestingly, the depolarization-induced Ca2+ transient in
the presence of intact mitochondria was smaller in ampli-
tude than with G93A mitochondria; excess Ca2+ emerged
in the second response and was prominent in WT cells
(Figs. 2A–C). This reflects the variability in Ca2+ clearing
The simultaneous measurement of cytosolic (Fura-2) and mitochondrial (Rhod-2) calcium concentrations in WT and G93A  transfected transfected SH-SY5Y cells during FCCP-evoked mitochondrial Ca2+ release Figure 5
The simultaneous measurement of cytosolic (Fura-2) and mitochondrial (Rhod-2) calcium concentrations in 
WT and G93A transfected transfected SH-SY5Y cells during FCCP-evoked mitochondrial Ca2+ release. A) The 
kinetic profile of the FCCP-evoked Ca2+ release in the WT transfected SH-SY5Y neuroblastoma cells; the cytosolic (Error bar 
green, black square trace) and mitochondrial (Error bar red, black circle trace) compartment were measured simultaneously. 
The trace represents the mean of 5 cells in focus stimulated with 2µM FCCP (5 point smoothing).  B) The corresponding 
kinetic profile of the FCCP-evoked Ca2+ release in the G93A transfected SH-SY5Y neuroblastoma cells; the cytosolic (Error 
bar green, black square trace) and mitochondrial (Error bar red, black circle trace) compartment were measured simultane-
ously. The trace represents the mean of 5 cells in focus stimulated with 2µM FCCP (5 point smoothing). FCCP-evoked 
[Ca2+]mito signals were smaller in amplitude and exhibited slower kinetics in G93A transfected SH-SY5Y cells compared to 
WT transfected cells and were altered from [Ca2+]i efflux. C) A bar diagram of the cytosolic (green bar) and mitochondrial 
(red bar) fluorescence signals (F/F0) from WT (F/F0 = 0.1569 ± 0.0235 for [Ca2+]i and F/F0 = -0.1069 ± 0.0181 for [Ca2+]mito; 
hollow; N=5,  n=17) and G93A (F/F0 = 0.1008 ± 0.0248 for [Ca2+]i and F/F0 = -0.0486 ± 0.0043 for[Ca2+]mito; striped pattern, 
N=4; n=17) transfected SH-SY5Y neuroblastoma cells. Values represent means ± SD, **p<0.001. N= Number of experiments; 
n= Number of cells.BMC Neuroscience 2009, 10:64 http://www.biomedcentral.com/1471-2202/10/64
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mechanisms of ALS-vulnerable and non-vulnerable MNs
and agrees with data obtained from motor nerve termi-
nals [72], cultured MNs [25], and patch-clamped
hypoglossal MNs [52] in which significant mitochondrial
Ca2+ uptake following voltage-activated Ca2+ influx was
demonstrated. We observed that the depolarization-
induced stimulus not only interfered with the post-depo-
larization recovery of [Ca2+]i after FCCP challenge but
also increased the peak amplitude of the FCCP-evoked
Ca2+ influx by approximately 40 and 68% in WT and
G93A cells, respectively (compare Figs. 1D and 2C).
Therefore, it is evident that in the absence of mitochon-
drial Ca2+ uptake, the [Ca2+]i signal is stronger, and mito-
chondria can actively sequester Ca2+ during an on-going
Ca2+ influx as a result of the opening of voltage-gated cal-
cium channels. A significant difference in the Ca2+ accu-
mulation by mitochondria in G93A and WT cells was
observed and presumably due to G93A-mediated toxicity.
Caffeine stimulates [Ca2+]i release with slower kinetics and weaker transient than the FCCP-evoked [Ca2+]i signals in SH-SY5Y  neuroblastoma cells, particularly in WT transfected cells compared to G93A transfected cells Figure 6
Caffeine stimulates [Ca2+]i release with slower kinetics and weaker transient than the FCCP-evoked [Ca2+]i 
signals in SH-SY5Y neuroblastoma cells, particularly in WT transfected cells compared to G93A transfected 
cells. A) The kinetic profile of caffeine and FCCP-evoked [Ca2+]i release in the WT transfected SH-SY5Y neuroblastoma cells. 
The trace is representative of 5 cells in focus stimulated with 5mM caffeine and 2µM FCCP (normalized data, 5 point smooth-
ing). B) The corresponding kinetic profile of the caffeine and FCCP-evoked [Ca2+]i release in the G93A transfected SH-SY5Y 
cells. The trace is representative of 5 cells in focus stimulated with 5mM caffeine and 2µM FCCP (normalized data, 5 point 
smoothing). The ER and mitochondrial Ca2+ release from these two compartments were measured simultaneously. The hori-
zontal black bars indicate the duration of stimulation by caffeine and with FCCP plus caffeine. Fura-2 AM signals are repre-
sented as F/F0.  C) A bar diagram of caffeine and FCCP plus caffeine-induced Ca2+ release in the WT and G93A transfected 
SH-SY5Y neuroblastoma cells (N=3, n=14). Gray bars represent caffeine plus FCCP-induced Ca2+ release in WT (F/F0 = 
0.1883 ± 0.0584) and G93A (F/F0 = 0.1154 ± 0.0246) transfected SH-SY5Y cells. Striped bars represent caffeine-induced Ca2+ 
release in WT (F/F0 = 0.0471 ± 0.0190) and G93A (F/F0 = 0.0353 ± 0.0120) transfected cells. Values represent means ± SD, 
*p<0.01, **p<0.001. N= Number of experiments; n= Number of cells.BMC Neuroscience 2009, 10:64 http://www.biomedcentral.com/1471-2202/10/64
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The capacity of mitochondria to restore the Ca2+ buffering
capacity of cell organelles is heavily compromised in
G93A cells. The disturbance of Ca2+ trapping in intracellu-
lar storage sites and Ca2+ extrusion from the cells [41] may
account for the reduced oscillations of [Ca2+]i we
observed in G93A cells.
Molecular interaction underlying mitochondria-endo-
plasmic reticulum Ca2+ strores coupling was evaluated
using thapsi and FCCP. We assume that both ER and
mitochondrial intracellular pools participate in the gener-
ation of Ca2+ signals in SH-SY5Y cells shaping their spati-
otemporal Ca2+  signals patterns. Thapsi- induced
Ca2+release was significantly less than that evoked by
FCCP in WT and G93A transfected cells, and its kinetics
were more or less similar in both genotypes (Figs. 3A–C).
The application of thapsi on SH-SY5Y cells causing sepa-
rate Ca2+ release response was slightly more in WT trans-
fected cells than in G93A cells, indicating that, in the
context of the G93A transfection, the ER may slightly con-
tribute to the motor dysfunction. Furthermore, the appli-
cation of FCCP after emptying ER stores with thapsi
resulted in a separate release event, evident from the big-
ger [Ca2+]i increase. This release was higher than the gen-
eral Ca2+ release caused by FCCP without emptying ER in
WT transfected cells but not in G93A altered cells, which
suggests an uptake of the released Ca2+ from ER by mito-
chondria in WT transfected cells. This further indicates the
explicit action of FCCP in our working model system and
the existence of two separate intracellular Ca2+ stores, in
Low Ca2+ buffering and excitotoxicity under physiological stress and pathophysiological conditions in motor neuron (MNs) Figure 7
Low Ca2+ buffering and excitotoxicity under physiological stress and pathophysiological conditions in motor 
neuron (MNs). Low Ca2+ buffering in amyotrophic lateral sclerosis (ALS) vulnerable hypoglossal MNs exposes mitochondria 
to higher Ca2+ loads compared to highly buffered cells. Under normal physiological conditions, the neurotransmitter opens 
glutamate, NMDA and AMPA receptor channels, and voltage dependent Ca2+ channels (VDCC) with high glutamate release, 
which is taken up again by EAAT1 and EAAT2. This results in a small rise in intracellular calcium that can be buffered in the cell. 
In ALS, a disorder in the glutamate receptor channels leads to high calcium conductivity, resulting in high Ca2+ loads and 
increased risk for mitochondrial damage. This triggers the mitochondrial production of reactive oxygen species (ROS), which 
then inhibit glial EAAT2 function. This leads to further increases in the glutamate concentration at the synapse and further rises 
in postsynaptic calcium levels, contributing to the selective vulnerability of MNs in ALS.
Table 1: Differential peak amplitudes of [Ca2+]i release from different compartment of WT and SOD1 transfected SH-SY5Y cells after 
multidrugs intervention. 
FCCP K+FCCP Thapsi Thapsi+FCCP Oligo Oligo+FCCP Caffeine Caffeine+FCCP
WT 0.17 ± 0.03 0.24 ± 0.06 0.04 ± 0.01 0.27 ± 0.09 0.04 ± 0.01 0.22 ± 0.07 0.04 ± 0.01 0.18 ± 0.05
SOD1 0.09 ± 0.02** 0.14 ± 0.03** 0.02 ± 0.01* 0.12 ± 0.02** 0.02 ± 0.01* 0.08 ± 0.03** 0.03 ± 0.01* 0.11 ± 0.02**
Data are expressed as mean ± S.D.
* p < 0.01 and ** p < 0.001 compared with WT transfected SH-SY5Y cells.BMC Neuroscience 2009, 10:64 http://www.biomedcentral.com/1471-2202/10/64
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which the ER seems to play a minimal role in buffering
[Ca2+]i after Ca2+ loads are imposed in G93A transfected
cells, and the ER is most likely not impaired during ALS-
related motoneuron disease.
We found that ER of SH-SY5Y cells retained a very low
amount of calcium (after Ca2+ release with thapsi for 6
min application) compared with mitochondria after Ca2+
elevation by FCCP (3 min) indicating its low efficiency to
sequester Ca2+ in the WT and G93A transfected SH-SY5Y
cells, which was slightly higher in WT (Figs. 3A–C). This
indicates that the conventional mitochondrial Ca2+ stor-
ing function dominates ER Ca2+accumulation in these
cells. It is noteworthy that thapsi has a relatively very weak
effect on Ca2+ release in G93A transfected cells, indicating
that G93A alteration might also result in defects in ER
Ca2+ handling, which may perturb functional domain and
contribute to neurodegeneration. These data suggest that
the ER of SH-SY5Y cells does not play a significant role in
regulating [Ca2+]i at the basal level or after imposed
Ca2+loads in WT transfected cells; though minor ER con-
tribution to the dysfunction of Ca2+ loads did not ruled
out, suggesting that Ca2+dysregulation as a result of the
G93A transfection anticipates mitochondrial impairment.
Our hypothesis is strengthened by the fact that previously
we have shown quite similar results in an animal model
of SOD1G93A mice for fALS; where cyclopiazonic acid (a
specific inhibitor of Ca2+-ATPase led to a relatively slow
and weak increase of [Ca2+]i, which occurred with slightly
higher kinetics in WT HMNs than the SOD1G93A mice
HMNs [62]. This finding alongwith our results in WT and
G93A transfected cells further explains that ER-dependent
Ca2+release is a minor contributor to mitochondria-medi-
ated toxicity in G93A transfected cells as previously
reported in other cell types and animal models [73,74].
Results indicate close coupling between ER and mito-
chondria in WT but not in G93A transfected cells which is
probably impaired due to G93A transfection. The thapsi-
releasable Ca2+ pool in WT and G93A transfected cells
(Figs 3A–C) was quite similar in quantity and temporal
quality release via RyR-sensitive Ca2+ pool by caffeine (see
Figs 4A–C). This observations suggests that Ca2+ uptake by
RyR-responsive pool is also sensitive to thapsi. These find-
ings also indicate that thapsi increases [Ca2+]i by inhibit-
ing Ca2+ uptake into multiple intracellular Ca2+ pools and
by also promoting entry of extracellular Ca2+ dominantly
in WT but not in G93A transfected cells. The exact molec-
ular interactions defining the organization of mitochon-
dria, ER and other Ca2+ sources varies among different cell
types, are questions that remain unanswered but are inter-
esting areas for future investigations.
We expect a decrease in cellular ATP levels during inhibi-
tion of mitochondrial electron transport by FCCP and this
may affect release of [Ca2+]i. To test the impact of ATP
depletion on regulation of [Ca2+]i, oligo (5 μg/ml) was
added before FCCP application. Oligo does not influence
[Ca2+]i heavily and left basal Ca2+ levels, as well as recov-
ery times of Ca2+ transients, unaffected for upto several
minutes (6 min application; Figs 5A–C) and therefore
amplitude of evoke [Ca2+]i transients was clearly attribut-
able to FCCP. Since application of oligo alone did not
affect the [Ca2+]i transients therefore the effect of FCCP is
clearly attributable to collapse of mitochondria, and not
to inhibition of ATP-synthesis. We assume that the time
course of ATP depletion by FCCP is slower but the
increase of cytosolic calcium by FCCP is immediate and
therefore there is no causal relationships have been dem-
onstrated between fall in ATP level and increase of [Ca2+]i.
These results are in agreement with those from studies of
SOD1G93A mice in sensitivity of HMNs mitochondria to
oligo [62].
Using the CCD camera imaging system, we clearly sepa-
rated the dynamic profiles of [Ca2+]i and [Ca2+]mito.
Using this method, we demonstrated that in WT cells, the
FCCP-evoked increase in [Ca2+]i was mainly due to
[Ca2+]i alone. However, in G93A cells, the FCCP-evoked
[Ca2+]i was less, exhibited slower kinetics, and reduced
[Ca2+]mito. This suggests that cells with G93A have a
lower affinity for mitochondrial Ca2+ upload and likely
represents severely disturbed and vulnerable mitochon-
dria. In this study, for the first time, the simultaneous
determination of [Ca2+]i and [Ca2+]mito in WT and G93A
transfected SH-SY5Y cells, a culture model of motor neu-
ron disease was achieved (Figs 6A–C). This data is in
agreement with previous findings that G93A cells exhibit
damaged and stressed mitochondria [6] and increased
ROS [47].
Different intracellular pools participate in the generation
of neuronal Ca2+ signals, shaping their spatio-temporal
patterns, and the cell life-death cycle. Mitochondria, in the
kinetic and hot spot hypothesis, and the ER, by different
classes of channels with distinct properties and highly
defined expression patterns, have been implicated in the
regulation of [Ca2+]i in many systems [41,42]. Caffeine
was used to investigate ER-dependent Ca2+ release and we
found that it evoked a small and slow increase in [Ca2+]i
with slightly faster kinetics in WT cells than G93A cells.
This further suggests that ER-dependent Ca2+ release has a
minor contribution in the mitochondria-mediated toxic-
ity of G93A. The rate of increase in Fura-2 fluorescence fol-
lowing caffeine application was slower and did not
resume the baseline, which is likely due to the slow activ-
ity of the mitochondrial Na+/Ca2+ exchanger, the major
pathway for mitochondrial Ca2+ efflux [75]. Observations
of different pharmacological conditions support the con-
cept that the presence of G93A severely disrupts mito-
chondrial Ca2+ regulation. It is also interesting to note thatBMC Neuroscience 2009, 10:64 http://www.biomedcentral.com/1471-2202/10/64
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the rate of increase in Fura-2 fluorescence signals follow-
ing caffeine application was slightly slower compared to
FCCP-evoked signals and did not achieve the baseline
within a few minutes. This suggests that the dye accumu-
lates in the mitochondria and the mitochondrial uptake
and release event is prominently operated by Ca2+ efflux
rather than by the store-operated Ca2+ uptake and release
phenomenon. Our fluorescence system may be a valuable
tool to determine mitochondrial and Ca2+-related defects
during G93A-mediated MN degeneration, which closely
parallels the incidence of neuronal death in G93A trans-
fected SH-SY5Y cells. Quantitative values of normalized
Fura-2 fluorescence signals after different drugs interven-
tions are compared in Table 1.
Despite rigorous research since Charcot's description
more than 130 years ago, the molecular abnormalities
leading to the damage of specific MNs in ALS are still
unknown. The selective vulnerability of MNs in ALS-
related disease and associated cell culture models is
closely linked to exceptional Ca2+ signaling mechanisms
that are part of the physiological cell function, but seem-
ingly also enhances the risk of Ca2+ homeostasis disrup-
tion and mitochondrial dysfunction in vulnerable cells.
Earlier studies suggested that uncontrolled Ca2+ entry and
inefficient calcium sequestering cause selective damage
leading to the formation of vacuoles derived from the
degenerating mitochondria in the MNs of the mouse
model of ALS [12,76,77]. In contrast to most other neu-
rons, MNs have a low Ca2+-buffering capacity due to the
low expression of Ca2+-buffering proteins and a high
number of Ca2+-permeable AMPA receptors resulting
from low expression of the GluR2 subunit. The combina-
tion of these two properties seems to be intrinsic to MNs
and is most likely essential for their normal function.
However, under pathological conditions, MNs may
become over-stimulated by glutamate and overwhelmed
by Ca2+; though, whether downstream pathways activated
by the intracellular Ca2+ increase are different in MNs
compared to other neurons is not yet known.
Conclusion
Our experiments identified specialized Ca2+ homeostasis
characterized by low cytosolic Ca2+ buffering in which
mitochondria play a major role in the regulation of [Ca2+]i
transients in vulnerable MNs. Low cytosolic Ca2+ buffer-
ing enhances the role of low affinity organelle buffers,
such as mitochondria, in the cell. For example, large and
long-lasting Ca2+ domains around influx sites enhance the
risk of toxic Ca2+ accumulations and subsequent activa-
tion of Ca2+-dependent neurodegenerative pathways
under excitotoxic conditions. Indeed, a strong contribu-
tion of mitochondria, as opposed to ER, Ca2+ uptake to
the buffering of Ca2+ profiles was recently demonstrated
[19,52,62]. There are two reasons that the prominent role
of mitochondria in the regulation of moderate Ca2+ loads
in MNs has important implications for pathological con-
ditions such as ALS. First, the amount of Ca2+ taken up by
the mitochondria is probably higher in MNs than other
cell types [25,78]. These high Ca2+ loads enhance the risk
for ROS generation, which may play a major role in initi-
ating the death cycle resulting in MN degeneration [29].
Second, our experiments provide evidence that cytosolic
Ca2+ depends on intact mitochondrial Ca2+ uptake. Thus,
when mitochondrial Ca2+ uptake is disturbed, as was seen
in G93A cells, MNs are directly put at risk of accumulating
basal Ca2+ levels during repetitive oscillations. Addition-
ally, the decreased ability to limit Ca2+ transient ampli-
tudes in the cytosol and, in particular, local domains
when mitochondria are depolarized enhances the risk of
initiating Ca2+  dependent neurodegenerative pathways
leading to cell death. A summary of the identified mecha-
nisms is given in Fig. 7; in vulnerable MNs, the calcium
buffering machinery is represented by the predominance
of mitochondria and calcium binding proteins.
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